Category: Diabetes
Europe Diabetes
-
Enteral Feeding Devices Market, By Product Type ( Feeding Tubes( Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector, Jejunostomy Tubes), By Age Group (ediatric, Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Enteral Feeding Devices Market, By ... Read More
-
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 ... Read More
-
Europe Durable Medical Equipment Market, By Product Type (Personal Mobility Devices, Medical Furniture & Bathroom Safety Devices, Monitoring & Therapeutic Devices); By End User (Hospitals, ASCs, Home Care Settings); By Application (Orthopedics. Cardiovascular, Respiratory, Diabetes Care, Neurology); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, The Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Care, Neurology); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, The Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Europe Durable Medical Equipment Market Size Expanding to Cross USD 78 ... Read More
-
Europe Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 7.20 billion by 2028, growing at a CAGR of 4.89% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Drugs Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
United Kingdom Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... in 2023 to USD 1.09 billion by 2028, at a CAGR of 6.72% during the forecast period (2023-2028). The COVID-19 pandemic had a substantial impact on the United Kingdom's diabetes care devices. According to The ... Read More
-
Europe Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 8.41 billion by 2028, at a CAGR of 3.40% during the forecast period (2023-2028). The COVID-19 epidemic significantly influenced the European Diabetes Medicines Market. As people with diabetes already have weakened immune systems, COVID-19 ... Read More
-
Spain Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.45 billion by 2028, growing at a CAGR of 4.50% during the forecast period (2023-2028). Spain has According to WHO, 102,258,825 vaccination doses have been delivered as of June 25, 2022. Regardless ... Read More
-
Spain Insulin Drugs And Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023, and is expected to reach USD 383.05 million by 2028, growing at a CAGR of 1.80% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 ... Read More
-
Spain Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 948 million by 2028, growing at a CAGR of 7.41% during the forecast period (2023-2028). In Sapin According to WHO, as of 25 June 2022, a total of 102,258,825 vaccine doses have been administered. ... Read More
-
Europe Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 10.21 billion by 2028, at a CAGR of 6.18% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Diabetes Care Devices Market. People with diabetes have a weak immune system ... Read More
-
Europe Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 650.23 million by 2028, growing at a CAGR of 3.85% during the forecast period (2023-2028). The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have been ... Read More
-
France Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3.22% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be ... Read More
-
Europe Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 117.35 million by 2028, growing at a CAGR of 1.20% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Insulin Syringe Market. People with diabetes have a weak immune system ... Read More
-
Italy Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.27 billion by 2028, growing at a CAGR of 6.70% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly ... Read More
-
Germany Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3.47% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people ... Read More
-
France Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.68 billion by 2028, growing at a CAGR of 6.58% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is ... Read More
-
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GlL[-1) Receptor Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... size is expected to grow from USD 9.20 billion in 2023 to USD 11.52 billion by 2028, at a CAGR of 4.61% during the forecast period (2023-2028). The COVID-19 epidemic has significantly affected the market ... Read More
-
United Kingdom (UK) Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.20 billion by 2028, at a CAGR of 3.05% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the United Kingdom's diabetes drugs market. According to The British Diabetic ... Read More
-
Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Pens Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
Italy Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 809.55 million by 2028, at a CAGR of 3.50% during the forecast period (2023-2028). The COVID-19 pandemic caused early fatalities during the first year of its existence, primarily in older people. The first nation ... Read More
-
Italy Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was ... Read More
-
Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Disease, and Other Disease Indication), Route of Administration (Intravenous, Subcutaneous, and Others), Drug Class (Granulocyte Colony-Stimulating Factor, Insulin, TNF Blockers and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region
... and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 ... Read More
-
Smart Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global smart medical devices market is witnessing remarkable growth, fueled by continuous advancements in digital health technologies and innovative customer-centric products. Smart medical devices utilize cutting-edge digital, networking, and sensor technologies to monitor, manage, ... Read More
-
Health Coaching Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global health coaching market is witnessing significant growth as consumers worldwide become increasingly aware of the benefits of disease prevention and maintaining a healthy lifestyle. Health coaching services, provided by trained professionals to help individuals ... Read More
-
Glycated Albumin Assay Market by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User (Hospitals & Diabetic Care Center, Diagnostic Laboratory) & Region (North America, Europe, APAC, Latin America, & MENA) - Global Forecast to 2028
... to 2028 The global glycated albumin assay market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 8.9% during the forecast period. Market growth is ... Read More
Research Assistance
